Zogenix (ZGNX) hikes as ban lifted

Zogenix (NASDAQ: ZGNX) shares gained 5.6% to $2.47 after the company reported that the court has granted temporary restraining order preventing the implementation of Massachusetts ban of Zohydro ER Extended-Release Capsules. Share volume was 385,000, compared to an all-day average of 710,000